Spironolactone for Female Pattern Hair Loss

Clinical Efficacy

The American Academy of Dermatology recommends spironolactone for female pattern hair loss, with 66% of women achieving clear or marked improvement at doses of 50-100 mg daily 1
Combination therapy with minoxidil and spironolactone shows a significantly better outcome than minoxidil and finasteride, with 56.7% achieving excellent response 1

The American Academy of Dermatology suggests starting with 100 mg daily in the evening, as this is the most commonly effective dose supported by guidelines 2
Doses range from 50-200 mg daily, with most patients responding to 100-150 mg daily 1
Several months of treatment is required to reach full effectiveness 2

The American Academy of Family Physicians recommends spironolactone for women with PCOS-related hair loss, as it addresses the underlying hyperandrogenism 3
Potassium monitoring is essential in patients with cardiovascular disease, renal impairment, or those taking ACE inhibitors, angiotensin receptor blockers, or digoxin 1

The American Academy of Dermatology reports that common side effects of spironolactone are dose-dependent, including menstrual irregularities (15-30%) and breast tenderness (3-17%) 2
Concomitant use of oral contraceptives or hormonal IUD minimizes the side effect of menstrual irregularities 2

The American Academy of Dermatology advises avoiding spironolactone in patients taking potassium supplements or potassium-sparing diuretics, and in those with significant renal, hepatic, or adrenal dysfunction 1
Patients should avoid high-potassium foods, such as low-sodium processed foods and coconut water 1
The Progress in Retinal and Eye Research journal warns against using spironolactone with potent CYP3A4 inhibitors or combined ACE inhibitor plus angiotensin receptor blocker 4

Spironolactone exhibits potent antiandrogen activity through multiple mechanisms, including decreasing testosterone production, competitively inhibiting binding of testosterone and dihydrotestosterone to androgen receptors in the skin, and increasing steroid hormone-binding globulin, making it effective for treating hirsutism, acne, and other androgen-related conditions in women 5
The American Academy of Dermatology guidelines support the use of spironolactone in the management of acne in select women, with a retrospective review showing 66% of women were clear or markedly improved at doses of 50-100 mg daily 5

Spironolactone at 100-150 mg daily achieves improvement in 85% of hirsute patients, with complete remission in 55%, making it a recommended add-on therapy when oral contraceptives alone provide inadequate response after 6-9 months, as suggested by the American College of Obstetricians and Gynecologists 6
The American Academy of Dermatology recommends starting with combined oral contraceptives as first-line therapy to suppress ovarian androgen secretion, and adding spironolactone 100-150 mg daily if inadequate response after 6-9 months of oral contraceptives alone 6

Both spironolactone and eplerenone require monitoring of serum potassium at baseline, 2-3 days, 7 days, monthly for 3 months, then every 3 months, with therapy held if potassium >5.5 mEq/L and discontinued if >6.0 mEq/L, as recommended by the American Heart Association 7
Hyperkalemia is a potentially serious side effect requiring vigilance, especially in patients with renal impairment, and patients should be advised to discontinue potassium supplements when initiating either agent, as recommended by the National Kidney Foundation 5